Evidence map›Paper›PMID 27114527›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Spatially distinct and metabolically active membrane domain in mycobacteria.

Jennifer M Hayashi, Chu-Yuan Luo, Jacob A Mayfield, Tsungda Hsu, Takeshi Fukuda, Andrew L Walfield, Samantha R Giffen, John D Leszyk, Christina E Baer, Owen T Bennion and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 90 citations in OpenAlex.

  1. Article
  2. Journal of bacteriology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Loss ofbioRxiv : the preprint server for biology · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Impact of MSMEG5257 Deletion onMicroorganisms · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Bacterial lipid biophysics and membrane organization.Current opinion in microbiology · 2023
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Supramolecular organization and dynamics of mannosylated phosphatidylinositol lipids in the mycobacterial plasma membrane.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 2 countries.

Jennifer M HayashiDepartment of Microbiology, University of Massachusetts, Amherst, MA 01003;
Chu-Yuan LuoDepartment of Microbiology, University of Massachusetts, Amherst, MA 01003;
Jacob A MayfieldDivision of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02445;
Tsungda HsuDepartment of Microbiology, University of Massachusetts, Amherst, MA 01003;
Takeshi FukudaDepartment of Immunoregulation, Research Institute for Microbial Diseases, Osaka University, Osaka, 565-0871, Japan;
Andrew L WalfieldDepartment of Microbiology, University of Massachusetts, Amherst, MA 01003;
Samantha R GiffenDepartment of Microbiology, University of Massachusetts, Amherst, MA 01003;
John D LeszykDepartment of Biochemistry and Molecular Pharmacology and Proteomics and Mass Spectrometry Facility, University of Massachusetts Medical School, Worcester, MA 01605;
Christina E BaerDepartment of Microbiology and Physiological Systems and Howard Hughes Medical Institute, University of Massachusetts Medical School, Worcester, MA 01605;
Owen T BennionDepartment of Microbiology & Molecular Biology, Tufts University School of Medicine, Boston, MA 02111;
Ashoka MadduriDivision of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02445;
Scott A ShafferDepartment of Biochemistry and Molecular Pharmacology and Proteomics and Mass Spectrometry Facility, University of Massachusetts Medical School, Worcester, MA 01605;
Bree B AldridgeDepartment of Microbiology & Molecular Biology, Tufts University School of Medicine, Boston, MA 02111; Department of Biomedical Engineering, Tufts University, Medford, MA 02155;
Christopher M SassettiDepartment of Microbiology and Physiological Systems and Howard Hughes Medical Institute, University of Massachusetts Medical School, Worcester, MA 01605;
Steven J SandlerDepartment of Microbiology, University of Massachusetts, Amherst, MA 01003;
Taroh KinoshitaDepartment of Immunoregulation, Research Institute for Microbial Diseases, Osaka University, Osaka, 565-0871, Japan; Laboratory of Immunoglycobiology, WPI Immunology Frontier Research Center, Osaka University, Osaka, 565-0871, Japan.
D Branch MoodyDivision of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02445;
Yasu S MoritaDepartment of Microbiology, University of Massachusetts, Amherst, MA 01003; ymorita@microbio.umass.edu.
University of Massachusetts Amherst · USUniversity of Massachusetts Chan Medical School · USHarvard University · USOsaka University · JPTufts University · US

Funding

Metabolomics Core U19AI111224 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI MOODY, DAVID BRANCH, MURRAY, MEGAN B · 2015 to 2021
$20.4M
T cell response to CDI-restricted lipids in tuberculosisR01AI049313 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI MOODY, DAVID BRANCH · 2001 to 2025
$10.6M
Tuberculosis Pathogenesis and Drug ResponseR01AI064282 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SASSETTI, CHRISTOPHER M · 2007 to 2017
$3.9M
Quantitative Design of Multi-drug Regiments for TuberculosisDP2LM011952 · NLM · TUFTS UNIVERSITY BOSTON · PI ALDRIDGE, BREE BEARDSLEY · 2013 to 2018
$2.9M
NIAID NIH HHS R01 AI049313NIAID NIH HHS R01 AI064282NIAID NIH HHS U19 AI111224NLM NIH HHS DP2 LM011952
6 · The paper itself

Abstract

Protected from host immune attack and antibiotic penetration by their unique cell envelope, mycobacterial pathogens cause devastating human diseases such as tuberculosis. Seamless coordination of cell growth with cell envelope elongation at the pole maintains this barrier. Unraveling this spatiotemporal regulation is a potential strategy for controlling mycobacterial infections. Our biochemical analysis previously revealed two functionally distinct membrane fractions in Mycobacterium smegmatis cell lysates: plasma membrane tightly associated with the cell wall (PM-CW) and a distinct fraction of pure membrane free of cell wall components (PMf). To provide further insight into the functions of these membrane fractions, we took the approach of comparative proteomics and identified more than 300 proteins specifically associated with the PMf, including essential enzymes involved in cell envelope synthesis such as a mannosyltransferase, Ppm1, and a galactosyltransferase, GlfT2. Furthermore, comparative lipidomics revealed the distinct lipid composition of the PMf, with specific association of key cell envelope biosynthetic precursors. Live-imaging fluorescence microscopy visualized the PMf as patches of membrane spatially distinct from the PM-CW and notably enriched in the pole of the growing cells. Taken together, our study provides the basis for assigning the PMf as a spatiotemporally distinct and metabolically active membrane domain involved in cell envelope biogenesis.

Indexed as

Bacterial ProteinsLipid MetabolismMembrane MicrodomainsMembrane ProteinsMycobacteriumBacterial ProteinsMembrane Proteinscell envelopelipid biosynthesismembrane domainmycobacteriapolar growth

Identifiers

PMID27114527
PMCPMC4868426
OpenAlexW2343291346

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.